Ixabepilone development across the breast cancer continuum: a paradigm shift
Nuhad K IbrahimDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAAbstract: The epothilone analog ixabepilone exhibits reduced susceptibility to several important tumor survival mechanisms that limit the efficacy of taxanes and anthracyclines. A...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-06-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/ixabepilone-development-across-the-breast-cancer-continuum-a-paradigm--a4719 |